Related Experiment Video
Updated: May 23, 2026
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Hypoxia and Oxidation Pathway Crosstalk in Head and Neck Squamous Cell Carcinoma
Abdullah A Adil1, Elizabeth Gensterblum-Miller1, John Henry Owen1
1Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Objective:
Treatment resistance remains a significant challenge in head and neck squamous cell carcinoma (HNSCC). Alterations in oxidative stress and hypoxia pathways predict poor therapeutic outcomes. The nuclear factor erythroid 2-related factor 2 pathway is the key regulator of oxidative stress response and an established mediator of treatment resistance. There is emerging evidence suggesting that its activation may influence hypoxia-inducible factor 1α (HIF-1α) signaling. However, this relationship remains poorly defined in HNSCC.
Study Design:
Translational research.
Setting:
University-based research laboratory.
Methods:
This study utilized bioinformatic and experimental approaches to investigate the relationship between NRF2 and HIF-1α expression. Correlations among KEAP1, NFE2L2 (NRF2), and HIF1A (HIF-1α) mRNA were examined using The Cancer Genome Atlas (TCGA) and RNA-sequencing data from patient-derived HNSCC cell lines. Functional validation was performed using siRNA-mediated KEAP1 knockdown in vitro, followed by quantitative polymerase chain reaction (PCR) and Western blot analysis.
Results:
TCGA analysis revealed that HIF1A mRNA positively correlated with NFE2L2 (NRF2), though the expression did not differ between NRF2 pathway-mutant and wild-type tumors. No significant correlation between HIF1A and NFE2L2 or KEAP1 mRNA was observed in HNSCC cell lines. KEAP1 knockdown achieved >90% transcript reduction and significantly increased the expression of the NRF2 target gene NQO1. Although NFE2L2 and HIF1A transcripts were unchanged, Western blot analysis demonstrated increased NRF2 and HIF-1α protein levels, suggesting a post-translational relationship.
Conclusion:
KEAP1 knockdown promotes NRF2 upregulation and HIF-1α protein accumulation in HNSCC independent of mRNA changes, suggesting protein-level or redox-mediated crosstalk between oxidative stress and hypoxia pathways.
Insights
Treatment resistance in head and neck squamous cell carcinoma (HNSCC) involves oxidative stress and hypoxia pathways. This study found that inhibiting KEAP1 increases nuclear factor erythroid 2-related factor 2 (NRF2) and hypoxia-inducible factor 1α (HIF-1α) protein levels, independent of mRNA changes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Treatment resistance is a major challenge in head and neck squamous cell carcinoma (HNSCC).
- Oxidative stress and hypoxia pathways are implicated in poor therapeutic outcomes in HNSCC.
- The nuclear factor erythroid 2-related factor 2 (NRF2) pathway regulates oxidative stress and treatment resistance, potentially interacting with hypoxia-inducible factor 1α (HIF-1α) signaling.
Purpose of the Study:
- To investigate the relationship between NRF2 and HIF-1α in HNSCC.
- To explore the role of KEAP1, NRF2, and HIF-1α in HNSCC treatment resistance.
Main Methods:
- Bioinformatic analysis of The Cancer Genome Atlas (TCGA) and RNA-sequencing data from HNSCC cell lines.
- Examined correlations between KEAP1, NFE2L2 (NRF2), and HIF1A (HIF-1α) mRNA expression.
- Functional validation using siRNA-mediated KEAP1 knockdown, quantitative PCR, and Western blot analysis.
Main Results:
- TCGA data showed a positive correlation between HIF1A and NRF2 mRNA, but not between HIF1A and NRF2/KEAP1 mRNA in HNSCC cell lines.
- KEAP1 knockdown significantly increased NRF2 target gene NQO1 expression.
- Western blot analysis revealed increased NRF2 and HIF-1α protein levels post-KEAP1 knockdown, despite unchanged mRNA levels.
Conclusions:
- KEAP1 knockdown enhances NRF2 upregulation and HIF-1α protein accumulation in HNSCC.
- This suggests a post-translational or redox-mediated crosstalk between oxidative stress and hypoxia pathways in HNSCC.
- Findings indicate potential therapeutic targets for overcoming treatment resistance in HNSCC.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:23Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
01:24Peroxisomes